Bioanalysis · 2015 · 12 citations · 22 references
PharmacyBiochemistryPharmaceutical AnalysisClinical BiochemistryMass Spectrometric AnalysisMetabolomicsAssay ValidationBioanalytical Method ValidationChromatographyClinical AnalysisLiquid ChromatographyAnalyte SolubilityAssayBlood-based BiomarkersClinical Biomarker ValidationDried Blood Spot AnalysisEfficacy Biomarker ValidationGaucher DiseasePrecision
BACKGROUND: Glucosylceramide, an efficacy biomarker for Gaucher Type 1 disease, exhibits poor solubility in polar solvents and whole blood which makes it difficult to prepare a homogenous blood standard. RESULTS: We developed a novel method using standard addition approach by spiking a small volume of analyte solution on the surface of prespotted dried blood spot. The whole spots were punched out for subsequent extraction and LC-MS/MS analysis. The assay performance met all validation acceptance criteria. Glucosylceramide concentrations in 50 paired plasma and dry blood spot samples obtained from Gaucher Type 1 patients were tested and the results demonstrated the feasibility of using the DBS method for clinical biomarker monitoring. CONCLUSION: The new approach greatly improves assay precision and accuracy.
22
Neil Spooner, Rakesh Lad, Matt Barfield · Analytical Chemistry · 2009 · 432 citations
Rebecca L. Shaner, Jeremy C. Allegood, Hye Jung Park et al. · Journal of Lipid Research · 2008 · 425 citations · Full text